ACCELERON PHARMA INC Insider Trading for April 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for April 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Option Exercise | M | 27.97 | 6,000 | 167,820 | 0 | |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 87.53 | 417 | 36,500 | 21,161 | 21.6 K to 21.2 K (-1.93 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 86.69 | 1,100 | 95,359 | 21,578 | 22.7 K to 21.6 K (-4.85 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 85.77 | 2,883 | 247,275 | 22,678 | 25.6 K to 22.7 K (-11.28 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 84.62 | 700 | 59,234 | 25,561 | 26.3 K to 25.6 K (-2.67 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 83.49 | 900 | 75,141 | 26,261 | 27.2 K to 26.3 K (-3.31 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Buy | M | 27.97 | 6,000 | 167,820 | 27,161 | 21.2 K to 27.2 K (+28.35 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 41.20 | 17,226 | 709,711 | 11,000 | |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 30.17 | 10,000 | 301,700 | 31,300 | |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 27.97 | 10,000 | 279,700 | 8,300 | |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 41.20 | 12,774 | 526,289 | 28,226 | |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 24.11 | 4,000 | 96,440 | 0 | |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 88.19 | 17,226 | 1,519,161 | 11,216 | 28.4 K to 11.2 K (-60.57 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 41.20 | 17,226 | 709,711 | 28,442 | 11.2 K to 28.4 K (+153.58 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 87.50 | 3,703 | 324,013 | 11,216 | 14.9 K to 11.2 K (-24.82 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 86.79 | 5,921 | 513,884 | 14,919 | 20.8 K to 14.9 K (-28.41 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 85.80 | 15,410 | 1,322,178 | 20,840 | 36.3 K to 20.8 K (-42.51 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 84.89 | 3,803 | 322,837 | 36,250 | 40.1 K to 36.3 K (-9.49 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 83.68 | 5,037 | 421,496 | 40,053 | 45.1 K to 40.1 K (-11.17 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 82.83 | 2,900 | 240,207 | 45,090 | 48 K to 45.1 K (-6.04 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 30.17 | 10,000 | 301,700 | 47,990 | 38 K to 48 K (+26.32 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 27.97 | 10,000 | 279,700 | 37,990 | 28 K to 38 K (+35.73 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 41.20 | 12,774 | 526,289 | 27,990 | 15.2 K to 28 K (+83.95 %) |
Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 24.11 | 4,000 | 96,440 | 15,216 | 11.2 K to 15.2 K (+35.66 %) |